[go: up one dir, main page]

Gali et al., 2024 - Google Patents

Nurturing Gut Health: Exploring Prebiotics and Probiotics for Gastrointestinal Wellness

Gali et al., 2024

Document ID
16800250438838398204
Author
Gali S
Reshma R
Harini A
Meenatchi R
Publication year
Publication venue
Traditional Foods: The Reinvented Superfoods

External Links

Snippet

The “microbiota” of humans, which consists of bacteria, fungus, bacteriophages, and viruses, functions as an “organ” in concert with the host to create an ecosystem. Skin, the genitourinary system, the respiratory system, and most importantly the gut is all capable of …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

Similar Documents

Publication Publication Date Title
You et al. The promotion mechanism of prebiotics for probiotics: A review
Roy et al. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives
He et al. Faecalibacterium prausnitzii: A next‐generation probiotic in gut disease improvement
Ramirez et al. Antibiotics as major disruptors of gut microbiota
Pushpanathan et al. Gut microbiota and its mysteries
Gallo et al. Modulation of microbiota as treatment for intestinal inflammatory disorders: an uptodate
JP6416308B2 (en) Use of purified 2'-fucosyl lactose, 3-fucosyl lactose, and lactodifucotetraose as prebiotics
Veerappan et al. Probiotics for the treatment of inflammatory bowel disease
Pandey et al. Probiotics, prebiotics and synbiotics-a review
Kolida et al. Synbiotics in health and disease
Phillips Gut reaction: environmental effects on the human microbiota
Haque et al. The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms–an appraisal
Tojo et al. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis
Chapman et al. Health benefits of probiotics: are mixtures more effective than single strains?
Tiwari et al. Promising future of probiotics for human health: Current scenario
Limdi et al. Do probiotics have a therapeutic role in gastroenterology?
Battaglini et al. The role of dysbiosis in critically ill patients with COVID-19 and acute respiratory distress syndrome
Markowitz et al. Probiotics in health and disease in the pediatric patient
Tian et al. Dietary fiber and its potential role in obesity: A focus on modulating the gut microbiota
Lou et al. Postbiotics as potential new therapeutic agents for sepsis
Haldar et al. Unravelling the gut-lung axis: insights into microbiome interactions and Traditional Indian Medicine's perspective on optimal health
Gulzar et al. Therapeutic potential of probiotics and prebiotics
Wu et al. A systematic review of the interaction between gut microbiota and host health from a symbiotic perspective
Goulet et al. Paediatricians play a key role in preventing early harmful events that could permanently influence the development of the gut microbiota in childhood
Parkes An overview of probiotics and prebiotics